Detalhe da pesquisa
1.
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
Haematologica
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450522
2.
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Am J Hematol
; 99(1): E1-E4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688525
3.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Am J Hematol
; 99(2): E63-E66, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100217
4.
Cladribine therapy for advanced and indolent systemic mastocytosis: Mayo Clinic experience in 42 consecutive cases.
Br J Haematol
; 196(4): 975-983, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34729775
5.
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Haematologica
; 107(4): 836-843, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348451
6.
A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
Am J Hematol
; 97(9): 1127-1134, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702875
7.
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
Br J Haematol
; 195(3): 413-416, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346084
8.
Venetoclax with azacitidine or decitabine in blast-phase myeloproliferative neoplasm: A multicenter series of 32 consecutive cases.
Am J Hematol
; 96(7): 781-789, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33844862
9.
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
Haematologica
; 105(1): 161-169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004014
10.
Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy.
Ann Hematol
; 98(2): 331-337, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334068
11.
Mast cell cytomorphology and treatment outcome in mast cell leukemia.
Am J Hematol
; 99(1): E5-E8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37732882
12.
Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide.
Am J Hematol
; 94(1): 5-9, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30252953
13.
Predictors of response to venetoclax plus hypomethylating agent therapy and survival in blastphase myeloproliferative neoplasm.
Haematologica
; 108(5): 1423-1428, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36519330
14.
Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival.
Haematologica
; 108(1): 245-249, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36073516
15.
Blast phase myeloproliferative neoplasm with prior exposure to ruxolitinib: comparative analysis of mutations and survival.
Haematologica
; 108(9): 2542-2545, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794509
16.
Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management.
Am J Hematol
; 93(4): 578-587, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512199
17.
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo-Moffitt study of 156 informative cases.
Am J Hematol
; 98(4): E76-E79, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36655582
18.
Multidisciplinary model to implement pharmacogenomics at the point of care.
Genet Med
; 19(4): 421-429, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27657685
19.
Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience.
Haematologica
; 107(10): 2474-2479, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734931
20.
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
Am J Hematol
; 97(4): E138-E140, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35015315